Johnson John

Director at XERS; Director at AXGN; Chief Executive Officer at CEMPRA, INC., and 1 more

Sold, on record
$3.9M
Dollars the filings state
Form 4 sales
8
Latest Jun 4, 2026
Form 144 notices
6
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

1
Routine
0
Plan not stated
1
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice AXGNNotice
    Dec 9, 2025 2025

    Filed to sell 21,686 shares ($650k)

    Johnson John, Director

    No 10b5-1 planFiling

  2. 2 Form 4 sale AXGNUnusual
    Dec 9, 2025 same day

    Sold 45,379 shares at $30.64 ($1.4M)

    Johnson John, Director

    No 10b5-1 planSold 100% of holdings ($1.4M position)0 shares leftFollows a Form 144Filing

  3. 3 Form 4 sale XERSNo plan
    Dec 19, 2025 +10 days

    Sold 135,400 shares at $7.22 ($978k)

    Johnson John, Director

    No 10b5-1 planSold 16.2% of holdings ($6M position)698,083 shares leftFollows a Form 144Filing

  4. 4 Form 144 notice XERSNotice
    Dec 19, 2025 same day

    Filed to sell 135,402 shares ($977k)

    Johnson John, Director

    No 10b5-1 planFiling

  5. 5 Form 144 notice AXGNNotice
    May 7, 2026 +139 days

    Filed to sell 11,050 shares ($478k)

    Johnson John, Director

    No 10b5-1 planFiling

  6. 6 Form 4 sale AXGNUnusual
    May 7, 2026 same day

    Sold 11,050 shares at $43.26 ($478k)

    Johnson John, Director

    No 10b5-1 planSold 100% of holdings ($478k position)0 shares leftFollows a Form 144Filing

  7. 7 Form 144 notice XERSNotice
    Jun 4, 2026 +28 days

    Filed to sell 15,000 shares ($88k)

    Johnson John, Director

    10b5-1 planFiling

  8. 8 Form 4 sale XERSRoutine
    Jun 4, 2026 same day

    Sold 15,000 shares at $6.09 ($91k)

    Johnson John, Director

    10b5-1 planSold 2.1% of holdings ($4.3M position)683,083 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Johnson John
Source
Jun 4, 2026Jun 5, 2026XERSDirectorForm 4 sale15,000$91k2.1%RoutineSEC
Jun 4, 2026Jun 4, 2026XERSDirectorForm 144 notice15,000$88kNoticeSEC
May 7, 2026May 8, 2026AXGNDirectorForm 4 sale11,050$478k100.0%UnusualSEC
May 7, 2026May 7, 2026AXGNDirectorForm 144 notice11,050$478kNoticeSEC
Dec 19, 2025Dec 19, 2025XERSDirectorForm 144 notice135,402$977kNoticeSEC
Dec 19, 2025Dec 19, 2025XERSDirectorForm 4 sale135,400$978k16.2%No planSEC
Dec 9, 2025Dec 10, 2025AXGNDirectorForm 4 sale45,379$1.4M100.0%UnusualSEC
Dec 9, 2025Dec 9, 2025AXGNDirectorForm 144 notice21,686$650kNoticeSEC
Dec 8, 2025Dec 8, 2025AXGNDirectorForm 144 notice23,693$740kNoticeSEC
Aug 13, 2025Aug 15, 2025XERSDirectorForm 4 sale107,500$787k11.4%No planSEC
Aug 13, 2025Aug 13, 2025XERSDirectorForm 144 notice107,500$786kNoticeSEC
Jun 9, 2025Jun 11, 2025AXGNDirectorForm 4 sale4,073$43k14.0%No planSEC
Jun 27, 2019Jul 2, 2019CEMPRA, INC.Chief Executive OfficerForm 4 sale13,000$72k25.8%UnusualSEC
Jan 3, 2012Jan 4, 2012SAVIENT PHARMACEUTICALS INCChief Executive OfficerForm 4 sale17,650$41k6.5%Plan not statedSEC